BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
calcium channel activity
,
Allergy to pollen
,
Lymphocyte
,
Hematopoietic cell
,
DNMT1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
receptors lysophosphatidic acid
Summary
General Info
Curated Studies
Most Correlated Studies
Endometrial cells treated with lysophosphatidic acid (LPA) and interferon tau (IFNt)
Breast and prostate cancer cell lines treated with lysophosphatidic acid
Mammary tumors from mice overexpressing ATX, LPA1, LPA2, or LPA3 in mammary epithelium
Prostate carcinoma PC-3M cells with siRNA knockdown of lysine-specific demethylase 1 (LSD1)
Explore Curated Studies Results
Literature
Most Relevant Literature
Autotaxin facilitates selective LPA receptor signaling.
Current progress in non-Edg family LPA receptor research.
Visualization of the binding between gintonin, a Panax ginseng-derived LPA receptor ligand, and the …
Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development.
Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis
Bile Acids Metabolism and Genetic Mutation Profile in the ICP in the Indian Population
To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding in Lung Using PET (Posi…
Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment
Safety, Tolerability, Kinetics, and Repeatability of the Novel LPA1 PET Ligand 18F-BMS-986327
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ